Recent advancements at ASCO 2024 in PD-L1 and PD-1 bispecific antibodies
Crossref DOI link: https://doi.org/10.1007/s12032-024-02559-3
Published Online: 2024-11-17
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hammad, Shaza
Boutros, Marc
Attieh, Fouad
Kourie, Hampig Raphaƫl
Text and Data Mining valid from 2024-11-17
Version of Record valid from 2024-11-17
Article History
Received: 5 October 2024
Accepted: 6 November 2024
First Online: 17 November 2024
Declarations
:
: The authors declare no competing interests.